We have a proven track record of strategic value-add

Why Us?

PV offers investment capital, health system expertise, and access to health system decision-makers, driving adoption and uncovering customer-level insights within and beyond.

Our value-add is real: every active portfolio company works with Providence.

At the same time, we target venture-class returns through direct investments in innovative healthcare companies that improve quality and convenience, lower cost, and improve health outcomes.

 Our Investment Strategy

We manage $300 million of venture capital across two funds on behalf of Providence. Engaging with dozens of distinct stakeholders across Providence, we have an intimate understanding of the innovation priorities for Providence and the overall US health system. Our greatest successes have come when the interests of our portfolio companies align with those priorities.

Our Funding Targets

We target a full spectrum of opportunities - from early-to-late stage investments. 

  • Healthcare IT / Digital Health and Tech-enabled Services

  • Medical Devices

  • Diagnostics

We welcome the opportunity to partner with established venture funds as co-investors, however, syndication is not a prerequisite for our participation.